Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Apr;7(4):379–383. doi: 10.1111/j.1365-2125.1979.tb00949.x

Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.

N Clausen, T Damsgaard, K Mellemgaard
PMCID: PMC1429639  PMID: 375959

Abstract

1 The antihypertensive effects at rest and during physical exercise of the non-selective beta-adrenoceptor blocker propranolol and the cardioselective beta-adrenoceptor blocker metoprolol were compared in a double-blind cross-over study. 2 Eighteen patients with mild hypertension entered the trial. One patient was withdrawn from the study due to side effects on both drugs. 3 The two beta-adrenoceptor blockers were compared using doses earlier shown to have the same beta-adrenoceptor blocking potency, as measured by their effect on exercise tachycardia in healthy men. 4 Arterial blood pressure was reduced to the same extent by propranolol and metoprolol at rest as well as during submaximal work. 5 It is concluded that the antihypertensive effect of beta-adrenoceptor blockers is mainly mediated through blockade of the beta 1-adrenoceptors.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bengtsson C. Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study. Acta Med Scand. 1976;199(1-2):71–74. doi: 10.1111/j.0954-6820.1976.tb06693.x. [DOI] [PubMed] [Google Scholar]
  2. Comerford M. B., Pringle A. Metoprolol in the long-term treatment of hypertension. Practitioner. 1976 Dec;217(1302):953–957. [PubMed] [Google Scholar]
  3. Hansson L., Aberg H., Jameson S., Karlberg B., Malmcrona R. Initial clinical experience with I.C.I. 66.082, a new beta-adrenergic blocking agent, in hypertension. Acta Med Scand. 1973 Dec;194(6):549–550. doi: 10.1111/j.0954-6820.1973.tb19489.x. [DOI] [PubMed] [Google Scholar]
  4. Hansson L., Aberg H., Karlberg B. E., Westerlund A. Controlled study of atenolol in treatment of hypertension. Br Med J. 1975 May 17;2(5967):367–370. doi: 10.1136/bmj.2.5967.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hansson L., Henningsen N. C., Karlberg B., Aberg H., Jameson S., Malmcrona R., Hersvall C. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent. Int J Clin Pharmacol. 1974 Oct;10(3):206–211. [PubMed] [Google Scholar]
  6. Hansson L., Westerlund A., Aberg H., Karlberg B. E. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. Eur J Clin Pharmacol. 1976 Mar 22;09(5-6):361–365. doi: 10.1007/BF00606549. [DOI] [PubMed] [Google Scholar]
  7. Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES